Xponance, Inc. Edwards Lifesciences Corp Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Xponance, Inc. holds 93,413 shares of EW stock, worth $6.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

93,413

Previous 92,293 1.21%

Holding current value

$6.33 Million

Previous $8.53 Million 27.7%

% of portfolio

0.06%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $66,864 - $105,033	1,120 Added 1.21%	93,413 $6.16 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $3.89 Million - $4.35 Million	-46,106 Reduced 33.31%	92,293 $8.53 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $41,928 - $55,233	-578 Reduced 0.42%	138,399 $13.2 Million
Q4 2023 Jan 31, 2024	SELL	$61.71 - $77.76 $134,898 - $169,983	-2,186 Reduced 1.55%	138,977 $10.6 Million
Q3 2023 Oct 23, 2023	BUY	$69.28 - $93.38 $157,473 - $212,252	2,273 Added 1.64%	141,163 $9.78 Million
Q2 2023 Jul 13, 2023	SELL	$81.41 - $94.33 $31,505 - $36,505	-387 Reduced 0.28%	138,890 $13.1 Million
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $176,664 - $201,049	2,379 Added 1.74%	139,277 $11.5 Million
Q4 2022 Jan 23, 2023	BUY	$68.3 - $87.44 $637,512 - $816,164	9,334 Added 7.32%	136,898 $0
Q3 2022 Oct 24, 2022	BUY	$82.37 - $107.29 $186,568 - $243,011	2,265 Added 1.81%	127,564 $10.5 Million
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $915,689 - $1.36 Million	-10,586 Reduced 7.79%	125,299 $11.9 Million
Q1 2022 Apr 20, 2022	BUY	$101.96 - $128.34 $142,234 - $179,034	1,395 Added 1.04%	135,885 $16 Million
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $962,861 - $1.18 Million	9,052 Added 7.22%	134,490 $17.4 Million
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $308,215 - $367,636	-2,995 Reduced 2.33%	125,438 $14.2 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $357,996 - $447,325	-4,270 Reduced 3.22%	128,433 $13.3 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $3.27 Million - $3.77 Million	41,596 Added 45.66%	132,703 $11.1 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $2.84 Million - $3.62 Million	-39,682 Reduced 30.34%	91,107 $8.31 Million
Q3 2020 Oct 26, 2020	SELL	$67.19 - $87.44 $571,719 - $744,026	-8,509 Reduced 6.11%	130,789 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $8.02 Million - $10.7 Million	139,298 New	139,298 $9.63 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account